US Cardiovascular Drugs Market Analysis

US Cardiovascular Drugs Market Analysis

$ 3999

US Cardiovascular Drug Market is at around $58.1 Bn in 2022 and is projected to reach $67.01 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The major reasons propelling the growth of this market are the increasing prevalence of chronic diseases, technological advancements, and the rise in government initiatives, among others. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., Astra Zeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.

ID: IN10USPH007 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Aneri Parekh

Buy Now

US Cardiovascular Drug Market Executive Summary

US Cardiovascular Drug Market is at around $58.1 Bn in 2022 and is projected to reach $67.01 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period.

Heart attacks, strokes, and venous thromboembolism fall under cardiovascular diseases since they impact the cardiovascular system as well as the blood and lymphatic vessels. The primary cause of heart attacks and strokes, which are typically acute events, is a blockage that stops blood flow to the brain or heart. Patients with heart conditions ought to have access to the right drugs and technologies. Aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins are examples of basic medications that ought to be accessible to patients.

The rising frequency of cardiovascular illness is fueling the steady rise of the US cardiovascular drug market. Market growth is aided by pharmaceutical developments, especially in the areas of anticoagulants and antihypertensives. The realities of the competitive landscape require that major firms concentrate on R&D for novel treatments and tactical alliances to keep their market leadership.

Pharma revenues increased dramatically over the preceding two decades, reaching $138.33 Bn globally in 2022. The pharmaceutical sector has seen a dramatic shift with the advent of new technology and more affordable and efficient manufacturing methods. In addition, the increasing flow of investments in this industry has contributed positively to the market's growth.

Bristol-Myers Squibb’s primary cardiovascular medications are the anticoagulant Eliquis, the antiplatelet medicine Apixaban, and the mTOR inhibitor Relion/Afinitor, which is used to treat heart failure. Despite some general rivalry in some markets, these contribute significantly to their revenue.

US cardiovascular drug market

Market Dynamics

Market Growth Drivers:

Increasing Prevalence of Cardiac Arrhythmias: Market growth is driven by the rising prevalence of cardiovascular diseases. It takes one life every 33 seconds. In 2021, approximately 0.7 Mn people died of heart disease.

Frequent Product Approvals: Market expansion is aided by frequent product approvals. In 2022, the FDA increased the use of empagliflozin (Jardiance).

Prevalence of Hypertension: The market for cardiovascular medications is boosted by the increased risk of cardiovascular illnesses brought about by the high incidence of hypertension among the population. The incidence of cardiovascular problems has grown among young people from emerging countries due to their extended work hours.

Market Restraints:

Strict Regulatory Process: Market growth is restricted by stringent regulatory processes such as lengthy approval procedures and dynamic safety criteria, which may delay the prompt launch of novel cardiovascular medications.

High Cost of Pharmaceuticals: The rising cost of pharmaceuticals can hamper the growth of the cardiovascular drug market in the US.

Expiration of Patents: Entry of generic alternatives into the market and the expiration of patents for important cardiovascular medications is the potential erosion of pharmaceutical companies' revenue due to increasing competition.

Notable Recent Updates

  • January 2023, following the patent expiration of Novartis's heart drug Sacubitril and Valsartan, Lupin Pharmaceuticals, a global player in drug discovery, launched the generic version of the combination drug. It will be marketed under two brand names, Valentas and Arnipin, and is intended for patients with heart failure

Healthcare Policies and Regulatory Landscape

Food and Drug Administration is the regulatory agency in charge of regulating cardiovascular medications in the US (FDA). The FDA is in charge of assessing and approving new medications, guaranteeing their efficacy. For the majority of novel therapeutic medications and biologics, the development process consists of three main stages: pre-clinical, clinical, and FDA review. Getting a license for cardiovascular medication is a challenging procedure that comes with a lot of obstacles like strict regulations, protracted and expensive development timelines, and clinical trial challenges.

Competitive Landscape             

Key Players:

  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Bayer AG
  • Janssen Pharmaceuticals, Inc.
  • Astra Zeneca
  • Sanofi
  • Novartis AG
  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • F. Hoffmann-La Roche Ltd

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Cardiovascular Drug Market Segmentation

By Drug Type

  • Cephalosporins
  • Antihypertensive
  • Antihyperlipidemic
  • Anticoagulants
  • Antiplatelet Drug
  • Other

By Disease Indication

  • Hypertension
  • Hyperlipidemia
  • Coronary Artery Disease
  • Arrhythmia
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 February 2024
Updated by: Bhanu Pratap Singh

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter